Hans J Hammers Selected Research

Hans J Hammers Research Topics

Disease

38	Renal Cell Carcinoma (Grawitz Tumor) 04/2024 - 06/2010
21	Neoplasms (Cancer) 04/2024 - 01/2004
6	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2010
4	Kidney Neoplasms (Kidney Cancer) 01/2021 - 01/2020
4	Fatigue 01/2020 - 11/2015
2	Hypertension (High Blood Pressure) 10/2019 - 07/2016
2	Body Weight (Weight, Body) 04/2018 - 11/2015
2	Disease Progression 01/2017 - 07/2016
2	Prostatic Neoplasms (Prostate Cancer) 10/2015 - 08/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024
1	Exanthema (Rash) 01/2024
1	Neutropenia 01/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Colitis 01/2022
1	Margins of Excision 01/2020
1	Stomatitis 01/2020
1	Pruritus (Itching) 01/2020
1	Dyspnea (Shortness of Breath) 10/2018
1	Nausea 10/2018
1	Diarrhea 10/2018
1	Melanoma (Melanoma, Malignant) 12/2017
1	Adenocarcinoma 12/2017
1	Carcinoma (Carcinomatosis) 12/2017
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 12/2017
1	Paraganglioma (Paragangliomas) 12/2017
1	Pheochromocytoma 12/2017
1	Adrenocortical Carcinoma 12/2017
1	Arthritis (Polyarthritis) 01/2017
1	Aspergillosis 07/2016
1	Aspiration Pneumonia 07/2016
1	Anemia 11/2015

Drug/Important Bio-Agent (IBA)

22	NivolumabIBA 01/2024 - 05/2015
15	Immune Checkpoint InhibitorsIBA 04/2024 - 09/2016
11	Sunitinib (Sutent)FDA Link 01/2022 - 06/2010
11	IpilimumabIBA 01/2022 - 12/2017
6	Everolimus FDA Link 01/2020 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2021
3	pazopanib FDA Link 03/2019 - 12/2017
3	Tyrosine Kinase InhibitorsIBA 12/2017 - 06/2010
2	cabozantinibIBA 10/2018 - 07/2016
2	Interleukin-2 (IL2)IBA 12/2017 - 12/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013 - 06/2010
1	PentosesIBA 04/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2024
1	Phosphates (Orthophosphate)IBA 04/2024
1	Epidermal Growth Factor (EGF)IBA 01/2024
1	B7-H1 AntigenIBA 01/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	Lipase (Acid Lipase)FDA Link 10/2019
1	Amylases FDA Link 10/2019
1	Alanine Transaminase (SGPT)IBA 10/2019
1	atezolizumabIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	4-carboxyphenylglyoxalIBA 12/2017
1	entinostat (MS 275)IBA 12/2017
1	Histone Deacetylase InhibitorsIBA 12/2017
1	tributyl phosphate (TBP)IBA 01/2017
1	Circulating Tumor DNAIBA 10/2016
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2016
1	AntigensIBA 01/2016
1	TabletsIBA 11/2015
1	QuercetinIBA 10/2015
1	Ellagic AcidIBA 10/2015
1	AndrogensIBA 10/2015
1	ResveratrolIBA 10/2015
1	Immunoglobulins (Immunoglobulin)IBA 06/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 08/2014
1	orteronelIBA 08/2014
1	SteroidsIBA 08/2014
1	AnticoagulantsIBA 05/2004
1	matrigelIBA 05/2004
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 05/2004
1	Peptides (Polypeptides)IBA 05/2004
1	VLDL receptorIBA 05/2004
1	withaferin AIBA 01/2004

Therapy/Procedure

17	Therapeutics 01/2022 - 06/2010
6	Immunotherapy 04/2024 - 01/2019
3	Nephrectomy 01/2024 - 12/2019
1	Drug Therapy (Chemotherapy) 01/2024
1	Duration of Therapy 01/2020
1	Length of Stay 01/2020
1	Metastasectomy 12/2019
1	Immunomodulation 12/2017
1	Castration 08/2014